An observational study in Brugada Syndrome, sponsored by Universitair Ziekenhuis Brussel. Status unknown at 1 site in Belgium. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2018-04-09.
Sponsored by Universitair Ziekenhuis Brussel · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
In this study the investigators analyse echocardiographic images before and during Ajmaline test. The purpose is to know if any echocardiographic modifications are present during either negative or positive Ajmaline testing.
The diagnosis of Brugada Syndrome is made when a type 1 pattern is present on the electrocardiogram (ECG), either spontaneously or after administration of a sodium channel blocker. For pathofysiological understanding, the investigators will analyse echocardiography images before and during the administration of Ajmaline. Comparing echocardiographies before and during negative Ajmaline test, will allow the investigators to indentify the effect of Ajmaline administration on cardiac function. The comparison between images of negative and positive Ajmaline tests will expose differences related to the occurence of a type 1 ECG.
53 studies on the registry are indexed under Brugada Syndrome; 19 are open to participants now.
This study's planned enrollment of 100 is below the median of 155 across 34 observational studies indexed under Brugada Syndrome.
Browse Brugada Syndrome studies →Universitair Ziekenhuis Brussel is the lead sponsor of 375 studies on the registry; 107 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients referred for Ajmaline test, either because of symptoms or in the context of familial screening.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
No appearance of a type 1 ECG during Ajmaline test
Drug: Ajmaline test
Appearance of a type 1 ECG during Ajmaline test
Drug: Ajmaline test
Administration of Ajmaline
Also known as: Echocardiography
Speckle tracking strain measurement
Cardiac function assessed by speckle tracking peak strain and peak strain dispersion
Time frame: 1 day at the time of enrollment
Plan to share: Undecided
No publications or documents are linked to this record.
Started Mar 2018 (actual). Primary completion is estimated for Mar 2019, 12 months after the start.
How these figures are worked out, and which studies are left out of them.
This study is status unknown, as verified in Apr 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Universitair Ziekenhuis Brussel →